Struma ovarii laboratory findings
|
Struma ovarii Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Struma ovarii laboratory findings On the Web |
|
American Roentgen Ray Society Images of Struma ovarii laboratory findings |
|
Risk calculators and risk factors for Struma ovarii laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
Laboratory findings consistent with the diagnosis of Struma ovarii include histopathologic studies and elevated CA 125 levels
Laboratory Findings
- Histopathologic studies may aid in diagnosing the malignant struma ovarii when there is no evidence of clinical malignancy or metastases. [1]
- Elevated levels of CA 125 has been reported rarely in approximately only 8-10 cases so far. [2] [3]
- However, in cases of metastatic struma ovarii post total thyroidectomy along with radioiodine scanning and radioiodine ablation, the thyroglobulin levels must be monitored as a tumor marker, and diagnostic radioiodine scans should be done to screen for residual or recurrent disease. [4]
References
- ↑ Kabukcuoglu F, Baksu A, Yilmaz B, Aktumen A, Evren I (2002). "Malignant struma ovarii". Pathol. Oncol. Res. 8 (2): 145–7. doi:PAOR.2002.8.2.0145 Check
|doi=value (help). PMID 12172581. - ↑ Mitrou S, Manek S, Kehoe S (2008). "Cystic struma ovarii presenting as pseudo-Meigs' syndrome with elevated CA125 levels. A case report and review of the literature". Int. J. Gynecol. Cancer. 18 (2): 372–5. doi:10.1111/j.1525-1438.2007.00998.x. PMID 18334015.
- ↑ Boselie F, Leeuwenberg E (1985). "Birkhoff revisited: beauty as a function of effect and means". Am J Psychol. 98 (1): 1–39. PMID 4003614.
- ↑ McGill JF, Sturgeon C, Angelos P (2009). "Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation". Endocr Pract. 15 (2): 167–73. doi:10.4158/EP.15.2.167. PMID 19289330.